Singh L, Singh G, Dinda AK. Understanding podocytopathy and its relevance to clinical nephrology. Indian journal of nephrology. 2015;25(1):1–7.
Article CAS PubMed Google Scholar
Wang X, Zhao J, Li Y, et al. Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression. Front Immunol. 2022;13: 1090989.
Article CAS PubMed Google Scholar
Trimarchi H, Coppo R. Podocytopathy in the mesangial proliferative immunoglobulin A nephropathy: new insights into the mechanisms of damage and progression. Nephrol Dial Transplant. 2019;34(8):1280–5.
Article CAS PubMed Google Scholar
Kostovska I, Trajkovska KT, Topuzovska S, et al. Nephrinuria and podocytopathies. Adv Clin Chem. 2022;108:1–36.
Article CAS PubMed Google Scholar
Kostovska I, Tosheska Trajkovska K, Kostovski O, et al. Urinary nephrin and podocalyxin levels as predictors of pre-eclampsia in high-risk pregnant women. Folia Med. 2021;63(6):948–57.
Kandasamy Y, Smith R, Lumbers ER, et al. Nephrin - a biomarker of early glomerular injury. Biomarker research. 2014;2: 21.
Banaszak B, Banaszak P. The increasing incidence of initial steroid resistance in childhood nephrotic syndrome. Pediatr Nephrol. 2012;27(6):927–32.
Article PubMed PubMed Central Google Scholar
Uwaezuoke SN. The role of novel biomarkers in childhood idiopathic nephrotic syndrome: a narrative review of published evidence. Int J Nephrol Renov Dis. 2017;10:123–8.
Sethna CB, Gipson DS. Treatment of FSGS in children. Adv Chronic Kidney Dis. 2014;21(2):194–9.
Bai J, Yin X, Li J, et al. Incidence, risk factors, and outcomes of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: a systematic review and meta-analysis. Clin Transplant. 2023;37(11): e15119.
Article CAS PubMed Google Scholar
Shabaka A, Tato Ribera A, Fernández-Juárez G. Focal segmental glomerulosclerosis: state-of-the-art and clinical perspective. Nephron. 2020;144(9):413–27.
Article CAS PubMed Google Scholar
McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011;26(2):414–30.
Sim JJ, Batech M, Hever A, et al. Distribution of biopsy-proven presumed primary glomerulonephropathies in 20002011 among a racially and ethnically diverse US population. Am J Kidney Dis. 2016;68(4):533–44.
Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clinical journal of the American Society of Nephrology : CJASN. 2017;12(3):502–17.
Article CAS PubMed Google Scholar
Harshman LA, Bartosh S, Engen RM. Focal segmental glomerulosclerosis: risk for recurrence and interventions to optimize outcomes following recurrence. Pediatr Transplant. 2022;26(6): e14307.
Sinha A, Bagga A. Nephrotic syndrome. Indian J Pediatr. 2012;79(8):1045–55.
Erichsen L, Thimm C, Bohndorf M, et al. Activation of the renin-angiotensin system disrupts the cytoskeletal architecture of human urine-derived podocytes. Cells. 2022;11(7):1095.
Article CAS PubMed Google Scholar
Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clinical journal of the American Society of Nephrology: CJASN. 2007;2(3):529–42.
Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am J Surg Pathol. 1998;22(4):419–24.
Article CAS PubMed Google Scholar
Hussein AM, Eldosoky M, Handhle A, et al. Effects of long-acting erythropoietin analog darbepoetin-α on adriamycin-induced chronic nephropathy. Int Urol Nephrol. 2016;48(2):287–97.
Article CAS PubMed Google Scholar
Elkholy IAGAMI, Mohammad MA, Zayed DHM, Elkalla HMHR, Elhilali AMA, Refat S. Pattern of expression of Delta-like ligand 4 (DLL-4) in patients with pancreatic ductal and ampullary adenocarcinomas and its clinicopathological prognostic implications. IP J Diagn Pathol Oncol. 2020;5(3):257–66.
Barisoni L, Lafata KJ, Hewitt SM, et al. Digital pathology and computational image analysis in nephropathology. Nat Rev Nephrol. 2020;16(11):669–85.
Article PubMed PubMed Central Google Scholar
Cazzaniga G, Rossi M, Eccher A, et al. Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions. J Nephrol. 2024;37(1):65–76.
Moustafa FE, Sobh MM. How to quantify podocytopenia in the clinical practice? A new step in computational renal pathology. Available at SSRN: https://doi.org/10.2139/ssrn.3987062.
Warejko JK, Tan W, Daga A, et al. Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clinical journal of the American Society of Nephrology : CJASN. 2018;13(1):53–62.
Article CAS PubMed Google Scholar
Chan EY, Yap DY, Colucci M, et al. Use of rituximab in childhood idiopathic nephrotic syndrome. Clinical journal of the American Society of Nephrology: CJASN. 2023;18(4):533–48.
Article PubMed PubMed Central Google Scholar
Carter SA, Mistry S, Fitzpatrick J, et al. Prediction of short- and long-term outcomes in childhood nephrotic syndrome. Kidney international reports. 2020;5(4):426–34.
Gomez AC, Gibson KL, Seethapathy H. Minimal change disease. Advances in kidney disease and health. 2024;31(4):267–74.
Chen D, Hu W. Lupus podocytopathy: a distinct entity of lupus nephritis. J Nephrol. 2018;31(5):629–34.
Ahmadian E, Eftekhari A, Atakishizada S, et al. Podocytopathy: the role of actin cytoskeleton. Biomed Pharmacother. 2022;156:113920.
Article CAS PubMed Google Scholar
AlYousef A, AlSahow A, AlHelal B, et al. Glomerulonephritis histopathological pattern change. BMC Nephrol. 2020;21(1):186.
Article CAS PubMed Google Scholar
Ibrahim S, Fayed A, Fadda S, et al. A five-year analysis of the incidence of glomerulonephritis at Cairo University Hospital-Egypt. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2012;23(4):866–70.
Oliva-Damaso N, Payan J, Oliva-Damaso E, et al. Lupus podocytopathy: an overview. Adv Chronic Kidney Dis. 2019;26(5):369–75.
Maas RJ, Nijenhuis T, van der Vlag J. Minimal change disease: more than a podocytopathy? Kidney international reports. 2022;7(4):675–7.
Sobh MM, El Kannishy G, Moustafa F, et al. Role of detached podocytes in differentiating between minimal change disease and early focal segmental glomerulosclerosis, can we rely on routine light microscopy? J Nephrol. 2022;35(9):2313–24.
留言 (0)